I
IMTXW
OtherImmatics N.V - Warrants (01/07/2025)
—PRE
Live · NASDAQ · May 8, Close
AI Insight
What's Moving IMTXW Today?
No stock-specific AI insight has been generated for IMTXW yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Market Cap—
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume—
Avg Volume (10D)—
Shares Outstanding—
IMTXW News
16 articles- All You Need to Know About Immatics (IMTX) Rating Upgrade to BuyYahoo Finance·May 6, 2026
- Immatics Announces Four Upcoming Oral Presentations Across Its Clinical Cell Therapy and Bispecific Portfolio at 2026 ASCO Annual MeetingYahoo Finance·Apr 21, 2026
- PRAME-directed Cell Therapy Using Immatics’ TCR Induces Deep and Durable Remission in Pediatric Patient with Advanced Metastatic NephroblastomaYahoo Finance·Apr 17, 2026
- Immatics Appoints Amie Krause as Chief People OfficerYahoo Finance·Oct 27, 2025
- Here's Why We're Not Too Worried About Immatics' (NASDAQ:IMTX) Cash Burn SituationYahoo Finance·Oct 22, 2025
- Immatics Says Anzu-cel Shows 'Strong' Anti-Tumor Activity in Uveal Melanoma Trial; Shares RiseYahoo Finance·Oct 20, 2025
- Immatics Appoints Venkat Ramanan as Chief Financial OfficerYahoo Finance·Oct 1, 2025
- Immatics N.V. (NASDAQ:IMTX) Analysts Just Slashed This Year's EstimatesYahoo Finance·Aug 18, 2025
- Immatics Second Quarter 2025 Earnings: Misses ExpectationsYahoo Finance·Aug 15, 2025
- Immatics (IMTX) Reports Q2 Loss, Misses Revenue EstimatesYahoo Finance·Aug 13, 2025
- Immatics: Q2 Earnings SnapshotYahoo Finance·Aug 13, 2025
- Immatics Announces Second Quarter 2025 Financial Results and Business UpdateYahoo Finance·Aug 13, 2025
- Here Is What You Need To Know Before Investing In Immatics N.V. (IMTX)Yahoo Finance·Jul 9, 2025
- Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic MelanomaYahoo Finance·May 31, 2025
- We're Hopeful That Immatics (NASDAQ:IMTX) Will Use Its Cash WiselyYahoo Finance·May 15, 2025
- Immatics Announces First Quarter 2025 Financial Results and Business UpdateYahoo Finance·May 13, 2025
All 16 articles loaded
Price Data
Open—
Previous Close—
Day High—
Day Low—
52 Week High—
52 Week Low—
Fundamentals
Market Cap—
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume—
Avg Volume (10D)—
Shares Outstanding—
About Immatics N.V - Warrants (01/07/2025)
Immatics N.V - Warrants (01/07/2025) (IMTXW) · Other
Listed July 2, 2020
Company Details
Security TypeStock
ExchangeNASDAQ
Currency—
Round Lot—
SIC—
CIK—
Composite FIGI—
Share Class FIGI—